Donaco International Limited

ASX:DNA Stock Report

Market Cap: AU$42.0m

Donaco International Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Donaco International.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Hospitality earnings growth14.7%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

Recent updates

Donaco International Limited (ASX:DNA) Doing What It Can To Lift Shares

Apr 24
Donaco International Limited (ASX:DNA) Doing What It Can To Lift Shares

Is Donaco International (ASX:DNA) Using Too Much Debt?

Mar 06
Is Donaco International (ASX:DNA) Using Too Much Debt?

Donaco International (ASX:DNA) Is Finding It Tricky To Allocate Its Capital

Jan 31
Donaco International (ASX:DNA) Is Finding It Tricky To Allocate Its Capital

Donaco International (ASX:DNA) Has A Somewhat Strained Balance Sheet

Dec 06
Donaco International (ASX:DNA) Has A Somewhat Strained Balance Sheet

Is Donaco International (ASX:DNA) Using Too Much Debt?

Mar 14
Is Donaco International (ASX:DNA) Using Too Much Debt?

Does Donaco International (ASX:DNA) Have A Healthy Balance Sheet?

Sep 01
Does Donaco International (ASX:DNA) Have A Healthy Balance Sheet?

Here's Why Donaco International (ASX:DNA) Can Afford Some Debt

Apr 06
Here's Why Donaco International (ASX:DNA) Can Afford Some Debt

Robust Earnings May Not Tell The Whole Story For Donaco International (ASX:DNA)

Sep 07
Robust Earnings May Not Tell The Whole Story For Donaco International (ASX:DNA)

Is Donaco International (ASX:DNA) A Risky Investment?

May 26
Is Donaco International (ASX:DNA) A Risky Investment?

How Much Did Donaco International's(ASX:DNA) Shareholders Earn From Share Price Movements Over The Last Five Years?

Feb 18
How Much Did Donaco International's(ASX:DNA) Shareholders Earn From Share Price Movements Over The Last Five Years?

Here's Why Donaco International (ASX:DNA) Can Afford Some Debt

Dec 25
Here's Why Donaco International (ASX:DNA) Can Afford Some Debt

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Donaco International has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

ASX:DNA - Analysts future estimates and past financials data (AUD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20233461718N/A
9/30/202329-161414N/A
6/30/202324-371111N/A
3/31/202318-4155N/A
12/31/202211-44-1-1N/A
9/30/20227-30-3-3N/A
6/30/20222-16-6-6N/A
3/31/20224-21-7-7N/A
12/31/20215-26-9-9N/A
9/30/20218-1-7-7N/A
6/30/20211025-5-5N/A
3/31/2021155-7-7N/A
12/31/202019-15-10-9N/A
9/30/202036-37-7-6N/A
6/30/202053-59-4-3N/A
3/31/202070-1111214N/A
12/31/201987-1632831N/A
9/30/201987-1802428N/A
6/30/201986-1982026N/A
3/31/201987-1131623N/A
12/31/201888-271220N/A
9/30/201891-762027N/A
6/30/201893-1252935N/A
3/31/2018107-1213237N/A
12/31/2017121-1183539N/A
9/30/2017129-43N/A43N/A
6/30/201713631N/A47N/A
3/31/201713555N/A39N/A
12/31/201613479N/A31N/A
9/30/201613879N/A41N/A
6/30/201614379N/A50N/A
3/31/201611145N/A55N/A
12/31/20157811N/A60N/A
9/30/2015483N/A34N/A
6/30/201519-5N/A9N/A
12/31/2014211N/A-5N/A
9/30/2014203N/AN/AN/A
6/30/2014215N/A10N/A
12/31/2013207N/A6N/A
9/30/2013208N/AN/AN/A
6/30/2013167N/A4N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if DNA's forecast earnings growth is above the savings rate (2.3%).

Earnings vs Market: Insufficient data to determine if DNA's earnings are forecast to grow faster than the Australian market

High Growth Earnings: Insufficient data to determine if DNA's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if DNA's revenue is forecast to grow faster than the Australian market.

High Growth Revenue: Insufficient data to determine if DNA's revenue is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if DNA's Return on Equity is forecast to be high in 3 years time


Discover growth companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.